Cookie preferences
This website uses cookies, which are necessary for the technical operation of the website and are always set. Other cookies, which increase the comfort when using this website, are used for direct advertising or to facilitate interaction with other websites and social networks, are only set with your consent.
Configuration
Technically required
These cookies are necessary for the basic functions of the shop.
"Allow all cookies" cookie
"Decline all cookies" cookie
CSRF token
Cookie preferences
Currency change
Customer-specific caching
FACT-Finder tracking
Individual prices
Selected shop
Session
Comfort functions
These cookies are used to make the shopping experience even more appealing, for example for the recognition of the visitor.
Note
Show the facebook fanpage in the right blod sidebar
Statistics & Tracking
Affiliate program
Conversion and usertracking via Google Tag Manager
Track device being used
Item number | Size | Datasheet | Manual | SDS | Delivery time | Quantity | Price |
---|---|---|---|---|---|---|---|
Cay38057-100 | 100 µg | - | - |
6 - 10 business days* |
377.00€
|
||
Cay38057-1 | 1 mg | - | - |
6 - 10 business days* |
2,446.00€
|
If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk
Receptor for advanced glycation end products (RAGE) is a transmembrane protein and member of the... more
Product information "RAGE (human, recombinant)"
Receptor for advanced glycation end products (RAGE) is a transmembrane protein and member of the IgG superfamily. It is composed of one V-type domain that is responsible for extracellular ligand binding, two C-type domains, a transmembrane domain, and a cytosolic tail involved in intracellular signaling. In addition to full-length and membrane-bound forms, soluble forms of RAGE can be formed either by proteolytic cleavage or alternative splicing. It is highly expressed in the mature lung pneumocytes and embryonic cells and is expressed at lower levels in many other cell types. RAGE has a variety of ligands that share a common structural motif, including AGEs, high mobility group box 1 (HMGB1), certain S100 proteins, and amyloid-beta peptide fibrils. Ligand activation of RAGE induces binding of the cytoplasmic tail to bridge proteins, such as diaphanous-related formin 1 (DIAPH1) and myeloid differentiation factor 88 adapter-like protein (Mal), which then activate MEK/ERK, PI3K/Akt, and JAK/STAT signaling pathways, among others, and lead to activation of NF-kappaB. RAGE levels increase rapidly at sites of inflammation, and full-length RAGE is associated with a pro-inflammatory state. Protein levels of RAGE are increased in postmortem coronary atherosclerotic lesions from patients with diabetes who died from sudden cardiovascular complications. However, plasma levels of soluble RAGE are lower in non-diabetic men with coronary artery disease (CAD) than those without CAD. Levels of full-length RAGE are decreased in non-small cell lung carcinoma (NSCLC) tissue compared with non-cancerous lung tissue, and proliferation of lung cancer cells overexpressing RAGE is reduced in vitro. Cayman's RAGE (human, recombinant) protein can be used for binding assays. This protein consists of 332 amino acids, has a calculated molecular weight of 35.5 kDa, and a predicted N-terminus of Ala23 after signal peptide cleavage. By SDS-PAGE, under reducing conditions, the apparent molecular mass of the protein is 47-53 kDa due to glycosylation.Synonyms: Advanced Glycosylation End Product-specific Receptor, AGER, Receptor for Advanced Glycosylation End Products. Purity: >98% estimated by SDS-PAGE. Endotoxin Testing: <1.0 EU/µg determined by the LAL endotoxin assay. Source: Active recombinant human His-tagged RAGE expressed in HEK293 cells. Amino Acids: 23-344. MW: 35.5 kDa. Formulation: (Request formulation change), Lyophilized from sterile PBS, pH 7.4. UniProt Accession #: Q15109.
Keywords: | AGER, RAGE, Receptor for advanced glycosylation end products, Receptor for advanced glycosylation end products, Advanced glycosylation end product-specific receptor, Advanced glycosylation end product-specific receptor |
Supplier: | Cayman Chemical |
Supplier-Nr: | 38057 |
Properties
Application: | Active |
Conjugate: | No |
Host: | Human cells |
Species reactivity: | human |
MW: | 35.5 kD |
Purity: | >98% estimated by SDS-PAGE |
Format: | Lyophilized |
Database Information
KEGG ID : | K19722 | Matching products |
UniProt ID : | Q15109 | Matching products |
Gene ID | GeneID 177 | Matching products |
Handling & Safety
Storage: | -80°C |
Shipping: | -80°C (International: -80°C) |
Caution
Our products are for laboratory research use only: Not for administration to humans!
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow.
more
You will get a certificate here
Viewed